Pharma News, 2016

Cheered by “extraordinarily high” efficacy in chemo-free combo studies, Roche is powering into late-stage trials with two different melanoma-fighting cocktails based on its brand-new immunotherapy...

ALLSCHWIL/BASEL, Switzerland November 7, 2016 I Actelion Ltd (SIX.

BERLIN, Germany I November 7, 2016 I Bayer today announced the submission of applications to extend the marketing authorization for its oral multi-kinase inhibitor regorafenib in the U.

The number of deaths from pancreatic cancer will overtake breast cancer mortality rates in the EU in 2017, a study has found.

Two prominent US lawmakers on Thursday called on US federal antitrust regulators to probe whether Sanofi SA, Eli Lilly and Co, Merck & Co Inc and Novo Nordisk A/S colluded to set prices for insuli...

When Valeant bought Sprout Pharmaceuticals and its controversial female libido drug Addyi, it agreed to a marketing blitz that would bring royalties to Sprout's former shareholders.

Allergan’s third-quarter numbers weren’t good.

The FDA has savaged a Chinese API maker in a warning letter for a long list of violations, including hiding questionable products, lying to inspectors about products made at the Beijing plant and syst...

Revenue reached DKK 11,469 million in the first nine months of 2016 representing an increase of 6%  compared to the same period last year    Revenue in the US increased 33%...

British patients could end up not being able to access modern medicines if there is a "hard Brexit", a think tank report endorsed by a former Conservative health minister warned on Wednesday...

Teva may be at a court’s mercy when it comes to IP protection for its long-lasting multiple sclerosis therapy, Copaxone.

SAN DIEGO, CA, USA I October 31, 2016 I ACADIA Pharmaceuticals Inc.